Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 16.00 / 505.56K |
Day Range | - - - |
52 Wk Range | 208.62 - 366.08 |
Market Cap | $15.71B |
P/E Ratio | 16.22 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 12.11% |
Days to Cover | 7.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of United Therapeutics (NASDAQ:UTHR) through any online brokerage.
Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
United Therapeutics has a consensus price target of $324.25.
The stock price for United Therapeutics (NASDAQ: UTHR) is $353 last updated September 20, 2024 at 5:22 PM EDT.
There are no upcoming dividends for United Therapeutics.
United Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for United Therapeutics.
United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.